The participants with PD in our study were well-medicated accordingly to their PD status, the medical treatment included: dopamine agonists, levodopa, monoamine oxidase B inhibitors, and anticholinergic agents, which all have several side effects that might affect oral health and orofacial function. The gene discussed is MAOB; the disease is Parkinson disease.